Published in Arch Pathol Lab Med on May 01, 1992
Clostridium difficile: clinical disease and diagnosis. Clin Microbiol Rev (1993) 2.19
Multicenter evaluation of four methods for Clostridium difficile detection: ImmunoCard C. difficile, cytotoxin assay, culture, and latex agglutination. J Clin Microbiol (1996) 1.49
Evaluation of four commercially available enzyme immunoassays for laboratory diagnosis of Clostridium difficile-associated diseases. J Clin Microbiol (1993) 1.28
Comparison of culture, cytotoxin assay and two EIA tests with clinical diagnosis of Clostridium difficile-associated diarrhea. Can J Infect Dis (1994) 0.75
Emergence of vancomycin resistance in coagulase-negative staphylococci. N Engl J Med (1987) 7.82
Recovery of resistant enterococci during vancomycin prophylaxis. J Clin Microbiol (1988) 5.71
Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr (1985) 4.26
Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis. J Clin Microbiol (1996) 3.20
Isolation medium for the recovery of Pseudomonas cepacia from respiratory secretions of patients with cystic fibrosis. J Clin Microbiol (1985) 3.09
Selective and differential medium for recovery of Pseudomonas cepacia from the respiratory tracts of patients with cystic fibrosis. J Clin Microbiol (1987) 2.59
Transmission of multidrug-resistant serotype 23F Streptococcus pneumoniae in group day care: evidence suggesting capsular transformation of the resistant strain in vivo. J Infect Dis (1995) 2.31
Nontuberculous mycobacteria in adult patients with cystic fibrosis. Chest (1992) 2.25
Improved recovery of mycobacteria from respiratory secretions of patients with cystic fibrosis. J Clin Microbiol (1993) 2.22
Invasive group A streptococcal infections in North Carolina: epidemiology, clinical features, and genetic and serotype analysis of causative organisms. J Infect Dis (1997) 2.09
Prevalence of thymidine-dependent Staphylococcus aureus in patients with cystic fibrosis. J Clin Microbiol (1987) 1.80
Biotype of Haemophilus influenzae: correlation with virulence and ampicillin resistance. J Infect Dis (1983) 1.78
Importance of culture in laboratory diagnosis of Bordetella pertussis infections. J Clin Microbiol (1984) 1.70
Relative frequency of Clostridium difficile in patients with diarrheal disease. J Clin Microbiol (1981) 1.56
Selection for vancomycin resistance in clinical isolates of Staphylococcus haemolyticus. J Infect Dis (1990) 1.54
Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Survival linked to genomovar type. Am J Respir Crit Care Med (2001) 1.52
Survival of human immunodeficiency virus in blood culture systems. Arch Pathol Lab Med (1988) 1.51
Multicenter evaluation of four methods for Clostridium difficile detection: ImmunoCard C. difficile, cytotoxin assay, culture, and latex agglutination. J Clin Microbiol (1996) 1.49
Nasopharyngeal carriage of antibiotic-resistant pneumococci by children in group day care. J Infect Dis (1988) 1.42
Inapparent transmission of Pseudomonas (Burkholderia) cepacia among patients with cystic fibrosis. Pediatr Infect Dis J (1994) 1.34
Evaluation of four commercially available enzyme immunoassays for laboratory diagnosis of Clostridium difficile-associated diseases. J Clin Microbiol (1993) 1.28
Clinical, laboratory, and environmental features of infant botulism in Southeastern Pennsylvania. Pediatrics (1985) 1.24
Comparative in vitro activity of LY146032 (daptomycin), a new lipopeptide antimicrobial. Eur J Clin Microbiol (1987) 1.21
Capnocytophaga ochracea septicemia. J Clin Microbiol (1981) 1.18
Nutritional requirements for synthesis of heat-labile enterotoxin by enterotoxigenic strains of Escherichia coli. Infect Immun (1979) 1.18
Sneakers as a source of Pseudomonas aeruginosa in children with osteomyelitis following puncture wounds. J Pediatr (1985) 1.16
Comparison of antimicrobial susceptibility methods for detection of penicillin-resistant Streptococcus pneumoniae. J Clin Microbiol (1995) 1.14
Utility of obtaining blood cultures in febrile neutropenic patients undergoing bone marrow transplantation. Bone Marrow Transplant (2000) 1.12
Evaluation of the campyslide agglutination test for confirmatory identification of selected Campylobacter species. J Clin Microbiol (1988) 1.09
Absorption of oral vancomycin - possible associated toxicity. Int J Pediatr Nephrol (1983) 1.08
The effects of panresistant bacteria in cystic fibrosis patients on lung transplant outcome. Am J Respir Crit Care Med (1997) 1.04
Clostridium difficile in patients with cystic fibrosis. Am J Dis Child (1985) 1.03
Clostridium difficile peritonitis in a neonate. A case report. Arch Pathol Lab Med (1984) 1.01
Pertussis is rare in human immunodeficiency virus disease. Am Rev Respir Dis (1993) 1.00
Evaluation of new monoclonal antibody-based latex agglutination test for detection of cryptococcal polysaccharide antigen in serum and cerebrospinal fluid. J Clin Microbiol (1994) 0.97
In vivo selection for transmissible drug resistance in Salmonella typhi during antimicrobial therapy. Antimicrob Agents Chemother (1990) 0.95
Clostridium difficile cytotoxin in a pediatric population. Am J Dis Child (1983) 0.93
Quality assurance study of bacterial antigen testing of cerebrospinal fluid. J Clin Microbiol (1995) 0.90
The use of a commercially available enzyme immunoassay for the detection of Clostridium difficile toxin A. Arch Pathol Lab Med (1993) 0.90
Immunological relationships between cholera toxin and Escherichia coli heat-labile enterotoxin. Infect Immun (1983) 0.90
Lung infection with Burkholderia gladioli in a child with cystic fibrosis: acute clinical and spirometric deterioration. Pediatr Pulmonol (1997) 0.89
Increased adherence of Staphylococcus aureus from cystic fibrosis lungs to airway epithelial cells. Am Rev Respir Dis (1993) 0.86
Antigenuria after Haemophilus influenzae type b polysaccharide immunization: a prospective study. J Pediatr (1986) 0.81
Antigenuria after Haemophilus influenzae type b polysaccharide vaccination. J Pediatr (1986) 0.81
Diarrheal disease in the hospitalized patient. Infect Control (1986) 0.79
Effect of imipenem-cilastatin therapy on fecal flora. Antimicrob Agents Chemother (1986) 0.77
Comparative in vitro activity of A-56268 (TE-031), a new macrolide antibiotic. Eur J Clin Microbiol (1987) 0.77
In vitro activity of orally administered antimicrobial agents against Haemophilus influenzae recovered from children monitored longitudinally in a group day-care center. Antimicrob Agents Chemother (1991) 0.77
In vivo and in vitro studies of Clostridium difficile-induced disease in hamsters fed an atherogenic, high-fat diet. Lab Anim Sci (1995) 0.76
Differentiation of Clostridium difficile toxin from Clostridium botulinum toxin by the mouse lethality test. Appl Environ Microbiol (1983) 0.75
Effect of lindane on nitroreductase and dechlorinase enzyme activity in the gastrointestinal tract. Toxicol Lett (1990) 0.75
Yersinia enterocolitica meningitis and osteomyelitis: a case report. Diagn Microbiol Infect Dis (1987) 0.75